Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

Endocrine therapy (ET) is recommended as first-line therapy for the majority of patients with hormone receptor-positive (HR+), human epidermal growth factor 2-negative advanced breast cancer (ABC); however, the efficacy of ET in patients with visceral metastases (VM) versus patients whose disease is...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, John F. R., Di Leo, Angelo, Johnston, Stephen, Chia, Stephen, Bliss, Judith M., Paridaens, Robert J., Lichfield, Jasmine, Bradbury, Ian, Campbell, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881093/
https://www.ncbi.nlm.nih.gov/pubmed/33579962
http://dx.doi.org/10.1038/s41523-021-00222-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881093/
https://www.ncbi.nlm.nih.gov/pubmed/33579962
http://dx.doi.org/10.1038/s41523-021-00222-y

Ejemplares similares